Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 20/9/2020
SIETES contiene 93097 citas

 1 a 20 de 153 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Franco OH, Chowdhury R, Troup J, Voortman T, Kunutsor S, Kavousi M, Oliver-Williams C, Muka T. Use of plant-based therapies and menopausal symptoms. A systematic review and meta-analysis. JAMA 2016;315:2554-63. [Ref.ID 100434]
2. Cita con resumen
Qaseem A, Barry MJ, Kansagara D, for the Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;164:350-9. [Ref.ID 99996]
3. Cita con resumen
Young K. NY attorney general: store-brand supplements rarely contain the herbs shown on the label. Physician's First Watch 2015:4 de febrero. [Ref.ID 98755]
5. Cita con resumen
Briggs JP, Killen J. Perspectives on complementary and alternative medicine research. JAMA 2013;310:691-2. [Ref.ID 95950]
6.Enlace a cita original
Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013;69:295-307. [Ref.ID 95150]
8.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
9.Enlace a cita original
Bosch M, Bonafont X. Efecte de l'ús de plantes medicinals en el període perioperatori. Butlletí d'Informació Terapèutica 2009;21:19-24. [Ref.ID 86922]
12.Tiene citas relacionadas
Stoney CM, Coates P, Briggs JP. Integrity of active components of botanical products used in complementary and alternative medicine. JAMA 2008;300:1995. [Ref.ID 84422]
13. Cita con resumen
Weber W, Stoep AV, McCarty RL, Weiss NS, Biederman J, McClellan J. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents. A randomized controlled trial. JAMA 2008;299:2633-41. [Ref.ID 83198]
14. Cita con resumen
Baxter K, Sharp JM. Adverse drug interactions. Adv Drug React Bull 2008;248:951-4. [Ref.ID 82877]
Andrén L, Andreasson A, Eggertsen R. Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients whith hypercholesterolemia. Eur J Clin Pharmacol 2007;63:913-6. [Ref.ID 81285]
16. Cita con resumen
Thanacoody RHK. Serotonin syndrome. Adv Drug React Bull 2007;243:931-4. [Ref.ID 81222]
Giner V, Papalardo E, Lafuente P, Esteban MJ. Fiebre prolongada por la ingesta de Hypericum perforatum (hierba de San Juan). Med Clin (Barc) 2007;129:356-7. [Ref.ID 81126]
18. Cita con resumen
Anónimo. MHRA reveals hot topics in drug safety. Scrip 2007;3294:6. [Ref.ID 81036]
Bell EC, Ravis WR, Lloyd KB, Stokes TJ. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics. Ann Pharmacother 2007;41:229-34. [Ref.ID 79491]
Singh SR, Levine MAH. Potential interactions between pharmaceuticals and natural health products in Canada. J Clin Pharmacol 2007;47:249-58. [Ref.ID 79247]
Seleccionar todas
 1 a 20 de 153 siguiente >>